Clinical Trial Update: Methotrexate in the Treatment of Axial Spondyloarthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating methotrexate for axial spondyloarthritis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Axial Spondyloarthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Rheumatism Foundation Hospital | Conditions: Spondylarthropathies, Spondylitis, Ankylosing | Phase 4 | Status: WITHDRAWN